ライフサイエンスコーパス: non-ischemic

1 ating the neovascularization of ischemic and non-ischemic adult mouse tissues, we utilized a hindlimb

2 necessity of urgent transplantation in both non-ischemic and ischemic HF patients (91% vs. 72%, p <

3 ion of IL-1beta protein in brain tissue from non-ischemic and ischemic mice using immunohistochemistr

4 Arterioles (60-110 microm) isolated from non-ischemic and ischemic regions of subepicardium were

5 up to 1 h (1.8-fold) post injury compared to non-ischemic and sham operated tissue.

6 seen in the control subjects (n = 3) or the non-ischemic basal ganglia of subjects undergoing 2-hour

7 Expression of tie 1 was not detected in non ischemic brain.

8 tor (statin) therapy on surrogate markers in non-ischemic cardiomyopathy (NICM) patients and average

9 The Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINI

10 ycardia Trial (MUSTT), the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINI

11 enrolled in the DEFINITE (DEFIbrillators in Non-Ischemic cardiomyopathy Treatment Evaluation) study.

12 tertiary referral centers, 228 patients with non-ischemic cardiomyopathy without history of CHF were

13 In patients with non-ischemic cardiomyopathy without history of CHF, myoc

14 ance of myocardial fibrosis in patients with non-ischemic cardiomyopathy without history of congestiv

15 dictors of recovery included: age <50 years, non-ischemic cardiomyopathy, time from cardiac diagnosis

16 R implantable cardioverter defibrillator AND non-ischemic cardiomyopathy.

17 ndard angiography or from other ischemic and non-ischemic causes that may confer increased risk for f

18 mulated wound repair under both ischemic and non-ischemic conditions in young animals, although it sh

19 with hindlimb ischemia compared with that in non-ischemic control mice.

20 Anesesthetized, non-ischemic control rats (N=6) were studied.

21 ated with 3-AB at doses of 55 mg/kg; and the non-ischemic control rats.

22 ebral ischemia compared to the sham-operated non-ischemic control.

23 The ischemic group had more cell death than non-ischemic controls as assessed by Trypan Blue exclusi

24 ntly more cell death (propidium iodide) than non-ischemic controls at 24 hr and significantly more ap

25 es (n=6), while the remaining dogs served as non-ischemic controls.

26 the vehicle-treated group and contralateral non-ischemic cortex.

27 ischemic cortex was compared to that in the non-ischemic cortex.

28 t adjacent to the ischemic lesion and in the non-ischemic cortex.

29 AO), brains were dissected into ischemic and non-ischemic cortices and Western blots were employed to

30 Non-ischemic dilated cardiomyopathy (DCM) has been recog

31 DS AND Ninety-nine patients with ischemic or non-ischemic dilated cardiomyopathy undergoing prophylac

32 (ACM) constitutes up to 40% of patients with non-ischemic dilated cardiomyopathy.

33 molecules have never been analysed in human non-ischemic dilated hearts (DCM).

34 hrine was observed in brain homogenates from non-ischemic DSP-4-treated rats compared with control.

35 re also determined in brain homogenates from non-ischemic DSP-treated and control rats.

36 The introduction of BDNF into non-ischemic ears or ischemic limbs induced neoangiogene

37 ysfunction (resulting from both ischemic and non-ischemic etiologies) and symptomatic chronic heart f

38 Patients With Left Ventricular Dysfunction, Non-ischemic Etiology in Primary Prevention Treated with

39 rowth factor-B even healed more rapidly than non-ischemic excisional wounds treated with vehicle (p <

40 The study population consisted of 8 non-ischemic failing (at LVAD implant) and 8 post-LVAD h

41 cardial lipid overload was present in 30% of non-ischemic failing hearts.

42 In Group 2 animals (n = 9), the (non-ischemic) frontal pole of the ipsilateral hemisphere

43 Ischemic and/or non-ischemic heart diseases (IHD and/or NIHD) were detec

44 al lipid accumulation is a common feature of non-ischemic heart failure and is associated with change

45 eart tissue from 27 patients (9 female) with non-ischemic heart failure.

46 aramedian cortex and thalamus), while in the non-ischemic hemisphere all regions measured showed sign

47 Few apoptotic cells were detected in the non-ischemic hemisphere of control rats.

48 ellular cytoplasm of control rats and in the non-ischemic hemisphere of rats subjected to MCAo.

49 o ADC decreases of about 30% compared to the non-ischemic hemisphere.

50 schemic hemisphere and in the contralateral (non-ischemic) hemisphere when compared to vehicle-treate

51 perfusion in the ischemic as well as in the non-ischemic hemispheres after permanent MCAo.

52 roved survival in patients with ischemic and non-ischemic HF.

53 in-B levels are altered in both ischemic and non-ischemic human heart failure.

54 diomyocyte cell death following ischemic and non-ischemic injuries.

55 g activity were observed in the ischemic and non-ischemic lesions in the mouse brain.

56 As additional controls, non-ischemic livers preserved with 6 hr of SCS or NELP a

57 increased equivalently in both ischemic and non-ischemic lobes, suggesting a more generalized role i

58 upregulated in ischemic tissue compared with non-ischemic matched pairs (p<0.001) and both TKR and VV

59 s LVDP and cardiac contractility in isolated non-ischemic murine hearts, prolongs ischemic contractur

60 ion of genetically engineered myoblasts into non-ischemic muscle led to an increase in vascular struc

61 Exposure of H(2) gas to non-ischemic neonates resulted in a significant increase

62 The fourth case underwent a non-ischemic open PN in the setting of a midpole tumor w

63 s in the ischemic CRVO group compared to the non-ischemic patients (P = 0.005, Fisher's exact test).

64 vels rose with exercise in both ischemic and non-ischemic patients.

65 brain edema, were measured in contralateral (non-ischemic), penumbra and densely ischemic brain regio

66 MASCs transplanted into non-ischemic pups survived but retained their astrocytic

67 2 calculated for cortical areas representing non-ischemic (Region A), perifocal/penumbral (Region B)

68 the hypothesis that neurons in ischemic and non-ischemic regions died from different mechanisms; spe

69 sions were increased in the border zones and non-ischemic remote regions of the post-ischemic heart.

70 n (68.9 +/- 4.6% vs. 89.3 +/- 3.0% reference non-ischemic septal segments; p < 0.001).

71 es of uninjured distal ischemic and proximal non-ischemic skin were harvested at below knee amputatio

72 was compared with patient- and site-matched non-ischemic skin.

73 ardioverter Defibrillators] in Patients With Non-Ischemic Systolic Heart Failure on Mortality) did no

74 Assess the Efficacy of ICDs in Patients With Non-Ischemic Systolic Heat Failure on Mortality) suggest

75 apoptosis occurs in the penumbra region and non-ischemic thalamus after cerebral ischemia.

76 elayed cell death in the ischemic cortex and non-ischemic thalamus.

77 ATP synthesis was attenuated in non-ischemic TNFalpha-Tg rats, demonstrated by reduction